trial · primary record
aldesleukin
Malignancy, Hematologic
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 86 |
| Primary completion | 2029-04-30 |
| Primary endpoint | Safety |
| Registry ID | NCT06904066 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:35.489Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06904066
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.